Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThis update changes the displayed site revision from v3.5.2 to v3.5.3 for the study details page, reflecting a platform/version release rather than any modification to the trial’s content.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check37 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. The change is limited to the page's version label and does not modify the study details or other content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded the term 'Primary peritoneal carcinoma' and included a new resource link to the Genetic and Rare Diseases Information Center. Page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.